Whitney Oliver, PA
Physician Assistant · Bentonville, ARNPI 1538714738
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,530, 2.7 times the $566 reported in 2021.
Across 109 payments — averaging $36.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$747
- AbbVie$738
- Novo Nordisk$681
- Inari Medical, Inc.$386
- Amgen$163
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$162
- plus $1K from 21 others
What the payments were for
- Food & beverage$4,002100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $747 |
| AbbVie | 18 | $738 |
| Novo Nordisk | 16 | $681 |
| Inari Medical, Inc. | 3 | $386 |
| Amgen | 5 | $163 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $162 |
| Otsuka America Pharmaceutical, Inc. | 2 | $122 |
| Idorsia Pharmaceuticals US Inc | 1 | $109 |
| Intuitive Surgical | 1 | $108 |
| Esperion Therapeutics, Inc. | 1 | $99 |
| GSK | 5 | $97 |
| Viiv Healthcare Company | 1 | $80 |
| Bayer | 4 | $74 |
| Boehringer Ingelheim | 4 | $66 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Merck | 2 | $37 |
| Corium, LLC | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Lundbeck LLC | 1 | $27 |
| Astellas Pharma US Inc | 1 | $21 |
| Gilead | 1 | $21 |
| Pfizer | 1 | $20 |
| Exact Sciences | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$410
- FARXIGA$250
- QULIPTA$246
- CT THROMBECTOMY SYSTEM KIT$166
- UBRELVY$125
- RYBELSUS$125
- Creon$125
- BREZTRI$122
- Ozempic$121
- QUVIVIQ$109
- Da Vinci Surgical System$108
How this compares
$4,002 in reported general payments places this provider in the 85th percentile of 451 physician assistant providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 30 | $32,341 |
| JardianceEmpagliflozin | 23 | $19,092 |
| EliquisApixaban | 17 | $18,816 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $18,344 |
| MounjaroTirzepatide | 12 | $13,115 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $9,601 |
| DilantinPhenytoin Sodium Extended | 12 | $1,725 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $1,131 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 36 | $665 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 63 | $587 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 35 | $546 |
| Doxycycline Hyclate | 59 | $532 |
| Prednisone | 92 | $510 |
| Potassium Chloride | 35 | $468 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 21 | $463 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $681 | $32,34130 claims |
| PfizerEliquis, Dilantin | $20 | $20,54129 claims |
| Boehringer IngelheimJardiance | $66 | $19,09223 claims |
| GSKTrelegy Ellipta | $97 | $18,34422 claims |
| Lilly USA, LLCMounjaro | $15 | $13,11512 claims |
| AstraZenecaBreztri Aerosphere | $747 | $9,60118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 451 physician assistant providers in Arkansas.
Other physician assistant in Bentonville
- Ryan CrowderBentonville$9K
- Brittany AguirreBentonville$7K
- Kara RichardsonBentonville$5K
- Jenny SimmonsBentonville$5K
- Teresa McKinneyBentonville$4K
- Honey SchaumburgFort Smith$397K
- Adrienne EasterlingRogers$366K
- Katherine RossLittle Rock$44K
- Benton LoggainsFort Smith$39K
- Monte DouglasJacksonville$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.